Literature DB >> 21926471

Terminating protein ubiquitination: Hasta la vista, ubiquitin.

Daniel K Stringer1, Robert C Piper.   

Abstract

Ubiquitination is a post-translational modification that generally directs proteins for degradation by the proteasome or by lysosomes. However, ubiquitination has been implicated in many other cellular processes, including transcriptional regulation, DNA repair, regulation of protein-protein interactions and association with ubiquitin-binding scaffolds. Ubiquitination is a dynamic process. Ubiquitin is added to proteins by E3 ubiquitin ligases as a covalent modification to one or multiple lysine residues as well as non-lysine amino acids. Ubiquitin itself contains seven lysines, each of which can also be ubiquitinated, leading to polyubiquitin chains that are best characterized for linkages occurring through K48 and K63. Ubiquitination can also be reversed by the action of deubiquitination enzymes (DUbs). Like E3 ligases, DUbs play diverse and critical roles in cells. ( 1) Ubiquitin is expressed as a fusion protein, as a linear repeat or as a fusion to ribosomal subunits, and DUbs are necessary to liberate free ubiquitin, making them the first enzyme of the ubiquitin cascade. Proteins destined for degradation by the proteasome or by lysosomes are deubiquitinated prior to their degradation, which allows ubiquitin to be recycled by the cell, contributing to the steady-state pool of free ubiquitin. Proteins destined for degradation by lysosomes are also acted upon by both ligases and DUbs. Deubiquitination can also act as a means to prevent protein degradation, and many proteins are thought to undergo rounds of ubiquitination and deubiquitination, ultimately resulting in either the degradation or stabilization of those proteins. Despite years of study, examining the effects of the ubiquitination of proteins remains quite challenging. This is because the methods that are currently being employed to study ubiquitination are limiting. Here, we briefly examine current strategies to study the effects of ubiquitination and describe an additional novel approach that we have developed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926471      PMCID: PMC3685619          DOI: 10.4161/cc.10.18.17191

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  29 in total

1.  Regulation of ubiquitin-binding proteins by monoubiquitination.

Authors:  Daniela Hoeller; Nicola Crosetto; Blagoy Blagoev; Camilla Raiborg; Ritva Tikkanen; Sebastian Wagner; Katarzyna Kowanetz; Rainer Breitling; Matthias Mann; Harald Stenmark; Ivan Dikic
Journal:  Nat Cell Biol       Date:  2006-01-22       Impact factor: 28.824

Review 2.  Biogenesis and function of multivesicular bodies.

Authors:  Robert C Piper; David J Katzmann
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

3.  Polyubiquitination by HECT E3s and the determinants of chain type specificity.

Authors:  Hyung Cheol Kim; Jon M Huibregtse
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

Review 4.  The ubiquitylation machinery of the endoplasmic reticulum.

Authors:  Christian Hirsch; Robert Gauss; Sabine C Horn; Oliver Neuber; Thomas Sommer
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

5.  Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II.

Authors:  Lin Wang; Huiping Dong; Carol J Soroka; Ning Wei; James L Boyer; Mark Hochstrasser
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

Review 6.  DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors.

Authors:  Sajjad Hussain; Ying Zhang; Paul J Galardy
Journal:  Cell Cycle       Date:  2009-06-01       Impact factor: 4.534

7.  Substrate- and ubiquitin-dependent trafficking of the yeast siderophore transporter Sit1.

Authors:  Zoi Erpapazoglou; Marine Froissard; Isabelle Nondier; Emmanuel Lesuisse; Rosine Haguenauer-Tsapis; Naïma Belgareh-Touzé
Journal:  Traffic       Date:  2008-05-17       Impact factor: 6.215

8.  Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation.

Authors:  Ping Xu; Duc M Duong; Nicholas T Seyfried; Dongmei Cheng; Yang Xie; Jessica Robert; John Rush; Mark Hochstrasser; Daniel Finley; Junmin Peng
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

9.  The ubiquitin-interacting motif protein, S5a, is ubiquitinated by all types of ubiquitin ligases by a mechanism different from typical substrate recognition.

Authors:  Tomoaki Uchiki; Hyoung Tae Kim; Bo Zhai; Steven P Gygi; Jennifer A Johnston; John P O'Bryan; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

10.  K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway.

Authors:  Elsa Lauwers; Christophe Jacob; Bruno André
Journal:  J Cell Biol       Date:  2009-04-27       Impact factor: 10.539

View more
  11 in total

1.  The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.

Authors:  Jayoung Kim; Wun-Jae Kim; Zhiqian Liu; Massimo Loda; Michael R Freeman
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

2.  Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.

Authors:  Claudia Lentucci; Anna C Belkina; Carly T Cederquist; Michelle Chan; Holly E Johnson; Sherry Prasad; Amanda Lopacinski; Barbara S Nikolajczyk; Stefano Monti; Jennifer Snyder-Cappione; Bogdan Tanasa; M Dafne Cardamone; Valentina Perissi
Journal:  J Biol Chem       Date:  2016-12-30       Impact factor: 5.157

3.  USP2a alters chemotherapeutic response by modulating redox.

Authors:  B Benassi; M Marani; M Loda; G Blandino
Journal:  Cell Death Dis       Date:  2013-09-26       Impact factor: 8.469

4.  Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue.

Authors:  Carly T Cederquist; Claudia Lentucci; Camila Martinez-Calejman; Vanessa Hayashi; Joseph Orofino; David Guertin; Susan K Fried; Mi-Jeong Lee; M Dafne Cardamone; Valentina Perissi
Journal:  Mol Metab       Date:  2016-10-31       Impact factor: 7.422

5.  Relief of the Dma1-mediated checkpoint requires Dma1 autoubiquitination and dynamic localization.

Authors:  Christine M Jones; Jun-Song Chen; Alyssa E Johnson; Zachary C Elmore; Sierra N Cullati; Janel R Beckley; Kathleen L Gould
Journal:  Mol Biol Cell       Date:  2018-07-05       Impact factor: 4.138

6.  Serum Exosomal miRNAs Are Associated with Active Pulmonary Tuberculosis.

Authors:  Shamila D Alipoor; Payam Tabarsi; Mohammad Varahram; Mehrnaz Movassaghi; Mehdi Kazempour Dizaji; Gert Folkerts; Johan Garssen; Ian M Adcock; Esmaeil Mortaz
Journal:  Dis Markers       Date:  2019-02-11       Impact factor: 3.434

7.  Disruption of AKAP-PKA Interaction Induces Hypercontractility With Concomitant Increase in Proliferation Markers in Human Airway Smooth Muscle.

Authors:  Hoeke A Baarsma; Bing Han; Wilfred J Poppinga; Saskia Driessen; Carolina R S Elzinga; Andrew J Halayko; Herman Meurs; Harm Maarsingh; Martina Schmidt
Journal:  Front Cell Dev Biol       Date:  2020-04-09

8.  Identification of Novel Molecular Network Expression in Acute Myocardial Infarction.

Authors:  Marwa Matboli; Ayman E Shafei; Sara H A Agwa; Sherif Sammir Elzahy; Ahmed K Anwar; Amr R Mansour; Ahmed I Gaber; Ali E A Said; Paula Lwis; Marwa Hamdy
Journal:  Curr Genomics       Date:  2019-08       Impact factor: 2.236

Review 9.  Interactions between SARS coronavirus 2 papain-like protease and immune system: A potential drug target for the treatment of COVID-19.

Authors:  Shahab Mahmoudvand; Somayeh Shokri
Journal:  Scand J Immunol       Date:  2021-08-10       Impact factor: 3.889

10.  ANTH domains within CALM, HIP1R, and Sla2 recognize ubiquitin internalization signals.

Authors:  Natalya Pashkova; Lokesh Gakhar; Liping Yu; Nicholas J Schnicker; Annabel Y Minard; Stanley Winistorfer; Ivan E Johnson; Robert C Piper
Journal:  Elife       Date:  2021-11-25       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.